Chronic obstructive pulmonary disease and the risk of stroke: A systematic review protocol

BMJ Open

Volumn 6, Issue 11, 2016, Pages

  Morgan, Ann D ^a   Sharma, Chetna ^b   Rothnie, Kieran J ^a,c   Quint, Jennifer K ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

COPD; systematic review protocol

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; METHODOLOGY; NEWCASTLE-OTTAWA SCALE; POPULATION EXPOSURE; RISK FACTOR; SYSTEMATIC REVIEW; COMORBIDITY; COMPLICATION; META ANALYSIS; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

COMORBIDITY; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 85000977721     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011898     Document Type: Article

References (18)

1. GOLD. Global strategy for the diagnosis, mangagement and prevention of chronic pulmonary disease (updated 2015). Global Initiative for Chronic Obstructive Lung Disease, 2015.
2. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-35.
3. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:155-61.
4. Müllerova H, Agusti A, Erqou S, et al. Cardiovascular comorbidity in COPD: systematic literature review. Chest 2013;144:1163-78.
5. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013;162:237-51.
6. Chen W, Thomas J, Sadatsafavi M, et al. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 2015;3:631-9.
7. Rothnie KJ, Yan R, Smeeth L, et al. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive disease (COPD): a systematic review and meta-analysis. BMJ Open 2015;5:e007824.
8. WHO. Health statistics and information systems: projection of mortality and causes of death, 2015 and 2030. Geneva: World Health Organization, 2015 (accessed 24 Nov 2015).
9. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010;65:956-62.
10. Finkelstein J, Cha E, Scharf S. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular comorbidity. Int J COPD 2009;4:337-49.
11. Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 2010;25:253-60.
12. Doehner W, Haeusler KG, Endres M, et al. Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease. Respir Med 2011;105(Suppl 1):S12-19.
13. Lahousse L, Tiemeier H, Ikram MA, et al. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med 2015;109:1371-80.
14. Arboix A, Morcillo C, Garcia-Eroles L, et al. Different vascular risk factor profiles in ischemic stroke subtypes: a study from the "Sagrat Cor Hospital of Barcelona Stroke Registry". Acta Neurol Scand 2000;102:264-70.
15. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647.
16. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007;36:666-76.
17. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: The Ottawa Hospital Research Institute. (http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp (accessed 4 Mar 2016)).
18. GRADE Working Group. GRADE working group [website]. Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group (http://www.gradeworkinggroup.org/ publications/JCE-series.htm (accessed 4 Mar 2016)).